An investor consortium led by British Arix Bioscience plc has put £13.4m into the Australian Pharmaxis Ltd,...
Up To Date
Latest News
As UK’s departure from the EU is fast approaching, stakeholders are preparing for the disruption a hard...
Antiviral drug discovery company ReViral announced the successful completion of a of a US$55m Series B...
The global market value of biodegradable plastics has passed the US$1.1bn mark in 2018, a report by IHS...
Swiss pharma giant Novartis announced that its monoclonal antibody for migraine prevention Aimovig (erenumab)...
A financing agreement with the European Investment Bank will allow the French cancer specialist Nanobiotix to...